FDA grants full approval for Pfizer-BioNTech coronavirus vaccine

The Food and Drug Administration (FDA) granted full approval to Pfizer-BioNTech’s coronavirus vaccine on Monday (Aug.23). 

That marks the first full approval for a COVID-19 vaccine in the U.S., and might pave the way for more vaccine mandates and ease concerns of those who are unvaccinated. 

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *